SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.

Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. · 2020

Read SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. by Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7375454.txt.

Introduction

Toyoshima and co-authors ask whether viral variants track national death rates, in the Journal of Human Genetics. Countries differed hugely in COVID-19 fatality, and the reasons were unclear. The team compared 12,343 SARS-CoV-2 genomes from six geographic areas against the reference sequence.

They counted 1,234 mutations and grouped 28 countries into three clusters with different fatality rates. Two linked variants, in ORF1ab and the spike protein, rose with fatality across countries. BCG vaccination status also tracked both fatality and case counts. The authors treat these as correlations needing care, since health systems and testing differ too. Readers get an early, cautious attempt to link viral genetics with outcomes.

Catalog record

CREATORToyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7375454

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19 By Yujiro Toyoshima, Kensaku Nemoto, Saki Matsumoto, Yusuke Nakamura, Kazuma Kiyotani Published in: Journal of Human Genetics DOI: 10.1038/s10038-020-0808-9 ABSTRACT The coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly expanded to a global pandemic. However, numbers of infected cases, deaths, and mortality rates related to COVID-19 vary from country to country. Although many studies were conducted, the reasons of these differences have not been clarified. In this study, we comprehensively investigated 12,343 SARS-CoV-2 genome sequences isolated from patients/individuals in six geographic areas and identified a total of 1234 mutations by comparing with the reference SARS-CoV-2 sequence. Through a hierarchical clustering based on the mutant frequencies, we classified the 28 countries into three clusters showing different fatality rates of COVID-19. In correlation analyses, we identified that ORF1ab 4715L and S protein 614G variants, which are in a strong linkage disequilibrium, showed significant positive correlations with fatality rates (r = 0.41, P = 0.029 and r = 0.43, P = 0.022, respectively). We found that BCG-vaccination status significantly associated with the fatality rates as well as number of infected cases. In BCG-vaccinated countries, the frequency of the S 614G variant had a trend of association with the higher fatality rate. We also found that the frequency of several HLA alleles, including HLA-A*11:01, were significantly associated with the fatality rates, although these factors were associated with number of infected cases and not an independent factor to affect fatality rate in each country. Our findings suggest that SARS-CoV-2 mutations as well as BCG-vaccination status and a host genetic factor, HLA genotypes might affect the susceptibility to SARS-CoV-2 infection or severity of COVID-19. INTRODUCTION The novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), was first reported in Wuhan, China in December 2019 [1, 2]. Soon after, the virus caused an outbreak in China and has spread to the world. According to the World Health Organization, the current outbreak of COVID-19 has nearly 11.5 million confirmed cases worldwide with more than 530,000 deaths, as of July 6, 2020. The SARS-CoV-2 genome comprises of around 30,000 nucleotides organized into specific genes encoding structural proteins and nonstructural proteins (Nsps) [1, 2]. Structural proteins include spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. Surface S glycoprotein is involved in the interaction with the host’s angiotensin-converting enzyme 2 (ACE2) receptor and plays an important role in rapid human to human transmission. Nsps, which are generated as cleavage products of the open reading frame 1ab (ORF1ab) viral polyproteins, assemble to facilitate viral replication and transcription. RNA-dependent RNA polymerase, also known as Nsp12, is the key component that regulates viral RNA synthesis with the assistance of Nsp7 and Nsp8 [3]. In addition, five accessory proteins are encoded by ORF3a, ORF6, ORF7a ORF8, and ORF10 genes. SARS-CoV-2 has rapidly spread around the world compared with SARS-CoV appeared in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012. Although the estimated fatality rate in the confirmed cases is 6.6% in SARS-CoV-2, which is lower than those of SARS-CoV and MERS-CoV, 9.6% and 34.3%, respectively [4], there is an urgent need for its effective treatment based on antivirals and vaccines that reduce the mortality and morbidity rates of COVID-19. However, up to now, the causes of the large country-by-country difference of the mortality rates related to COVID-19 have not been clearly understood. Although many studies were conducted, the effects of SARS-CoV-2 genetic variations and host genetic factors remain elusive. In this study, we comprehensively analyzed 12,343 SARS-CoV-2 genome sequences isolated from patients/individuals in six geographic areas, including Asia, North America, South America, Europe, Oceania, and Africa, and investigated their correlations to the fatality rates in 28 different countries. We also investigated the associations with BCG-vaccination status as well as human leukocyte antigen (HLA), which is an important molecule to recognize virus by our host immune system. METHODS Coronavirus sequences Full-length viral nucleotide sequence of the reference SARS-CoV-2 (accession number MN908947) [1] was downloaded from the NCBI GenBank. We used a total of 12,343 SARS-CoV-2 sequences isolated in 50 different countries of six geographic areas, including 1062 sequences from Asia, 4060 from North America, 99 from South America, 6012 from Europe, 1028 from Oceania, and 82 from Africa regions, which were deposited in the Global Initiative on Sharing Avian Influenza Data as of 7 May 2020 [5]. To analyze mutations based on countries, we used the data of 28 countries in which more than 30 SARS-CoV-2 sequences are available, among the 50 countries. Mutation analysis We analyzed mutations of SARS-CoV-2 as described previously [6]. Briefly, we first aligned each of the SARS-CoV-2 sequences to the reference sequence SARS-CoV-2_Wuhan-Hu-1 (accession number MN908947) using BLAT software [7]. After the alignment, we extracted nucleotide sequences corresponding to individual proteins of SARS-CoV-2, translated them into amino acid sequences, and then compared them to reference amino acid sequences of SARS-CoV-2_Wuhan-Hu-1 (accession numbers QHD43415-QHD43423, QHI42199). Data acquisition Data on numbers of confirmed cases and deaths related to COVID-19 were obtained from the Worldometer (https://www.worldometers.info/coronavirus/) on 7 May 2020 (Supplementary Table 1). Data of confirmed cases and deaths in each state in the United States were obtained on 3 July 2020. Fatality rate in infected individuals was calculated from total infected cases and total deaths in each country. The allelic frequencies of HLA genes were obtained from The Allele Frequency Net Database [8]. Data on BCG-vaccination status in each country were obtained from the previous reports [9–11]. Statistical analyses Continuous variables were compared using the Student’s t test. Fisher’s exact test was used to analyze differences of mutation rates of SARS-CoV-2 among the different geographic areas. A hierarchical clustering was performed to identify clusters corresponding to distinct subgroups with the selected mutations using R package stats. Global maps of clusters or mutations were drawn using R package rworldmap. Pearson’s correlation was used to evaluate correlations among mutant frequencies, HLA allele frequencies and fatality rates. Haploview software was used to analyze and visualize the haplotypes of SARS-CoV-2 mutations [12]. Multiple regression analysis was used to test for an independent contribution of identified factors to fatality rates of COVID-19. All statistical analyses were carried out using the R statistical environment version 3.6.1. RESULTS All replicating viruses, including coronavirus, continuously accumulate genomic mutations that persist due to natural selections. These mutations contribute to enhancement of ability of viral proliferation and infection as well as an escape from host immune attack. We firstly investigated mutations in 12,343 SARS-CoV-2 genome sequences isolated from patients/individuals in six different regions, including Asia, North America, South America, Europe, Oceania, and Africa. We identified a total of 1234 mutations detected in at least two independent samples, including 131 mutations found at a frequency of more than 10% (Supplementary Table 2). A hierarchical clustering using 16 common amino acid mutations classified 28 countries into three clusters (Fig. 1a). The cluster 1 includes most of the Asian countries we analyzed, whereas the cluster 2 includes European and South American countries, and the cluster 3 includes European, North American, Oceania, African and a few Asian countries (Fig. 1b). Comparing the mutations among the three clusters, the average frequency of an L variant of an

Read the complete text